Peer Support Intervention for Patients Undergoing Hematopoietic Stem Cell Transplantation — STEPP  

Hematopoietic Malignancy Clinical Trial

Official title: Peer Support Intervention for Patients Undergoing Hematopoietic Stem Cell Transplantation (STEPP): Feasibility and Preliminary Efficacy Trial

Status Recruiting

Clinical Trial Summary

The main purpose of this study is to determine if a novel peer support intervention (STEPP) is feasible among patients undergoing hematopoietic stem cell transplantation (HSCT). The name of the intervention used in this research study is STEPP, a peer support intervention comprised of five learning modules on psychoeducation and supportive psychotherapy strategies, tailored to the unique needs of patients undergoing HSCT.

Clinical Trial Description

The goal of this project is to refine a peer support intervention (STEPP) for patients undergoing hematopoietic stem cell transplantation (HSCT) and to conduct a randomized clinical trial to test its feasibility and preliminary efficacy for improving quality of life (QOL) and reducing psychological distress. Participants will be randomized into one of two study groups: Peer Support Intervention (STEPP) vs. Usual Care. Randomization means a participant is placed into a group by chance. Participants will have an equal chance of being placed in either group. Study procedures include screening for eligibility and questionnaires. Participation in this study is expected to last about 10 weeks. It is expected that about 80 people will participate in this randomized clinical trial. ;

Related Conditions & MeSH terms

• Hematologic Neoplasms
• Hematopoietic Malignancy
• Neoplasms

• NCT number: NCT06010017
• Study type: Interventional
• Source: Brigham and Women's Hospital
• Contact: Hermioni Amonoo, MD
• Phone: 617-732-4241
• Email: hermioni_amonoo@dfci.harvard.edu
• Status: Recruiting
• Phase: N/A
• Start date: February 20, 2024
• Completion date: July 31, 2026